Literature DB >> 216846

[Tangier-disease (author's transl)].

G Assmann.   

Abstract

Tangier disease is a rare autosomal recessive lipid transport disease characterized by the absence of the usual high density lipoproteins from plasma and cholesteryl ester storage in many organs. 25 cases of Tangier disease have been described so long. The predominant clinical symptoms include tonsilar hypertrophy, splenomegaly and peripheral neuropathy. The cholesteryl ester storage is limited to macrophages, Schwann's cells and intestinal smooth muscle cells. Hypocholest erolemia (less than 80mg/dl), hypertriglyceridemia (greater than 200 mg/dl), and the absence of high density lipoproteins in agarose electrophoresis are the major plasma abnormalities. The protein moiety of normal high density lipoprotein consists of apoprotein A-I and apoprotein A-II. In Tangier disease, serum concentrations of these apoproteins are reduced to less than 1% and 5-10%, respectively. Theories concerning the pathogenesis of Tangier disease are only incomplete and unproved up to now; however, a structural abnormality of apoprotein A-I causing an inability to bind to lipid or other proteins (apoprotein A-II) is consistent with several of the recent biochemical findings. The imbalance of cellular cholesterol metabolism caused by the absence of high density lipoproteins as well as the presumed role of these lipoproteins in cholesterol removal from cells are discussed in this article.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216846     DOI: 10.1007/bf01491335

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  43 in total

Review 1.  Lipoprotein metabolism.

Authors:  S Eisenberg; R I Levy
Journal:  Adv Lipid Res       Date:  1975

2.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

3.  Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts.

Authors:  N E Miller; D B Weinstein; T E Carew; T Koschinsky; D Steinberg
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  [Clinical and morphological findings in Tangier disease (hypo-alpha-lipoporteinaemia) and its ENT-significance (author's transl)].

Authors:  R Schröder; H Heckers
Journal:  Arch Otorhinolaryngol       Date:  1977-10-31

Review 5.  Lipoprotein structure and metabolism.

Authors:  R L Jackson; J D Morrisett; A M Gotto
Journal:  Physiol Rev       Date:  1976-04       Impact factor: 37.312

6.  Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture.

Authors:  E L Bierman; O Stein; Y Stein
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

7.  Familial alpha-lipoprotein deficiency (Tangier disease) with neurological abnormalities.

Authors:  R S Kocen; J K Lloyd; P T Lascelles; A S Fosbrooke; D Willims
Journal:  Lancet       Date:  1967-06-24       Impact factor: 79.321

8.  Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein.

Authors:  S E Lux; R I Levy; A M Gotto; D S Fredrickson
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  High density lipoprotein metabolism in man.

Authors:  C B Blum; R I Levy; S Eisenberg; M Hall; R H Goebel; M Berman
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

10.  [Familial analphalipoproteinemia (Tangier disease)].

Authors:  H Kummer; J Laissue; H Spiess; R Pflugshaupt; U Bucher
Journal:  Schweiz Med Wochenschr       Date:  1968-03-16
View more
  2 in total

1.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

Review 2.  [HDL cholesterol: clinical and pathobiochemical aspects (author's transl)].

Authors:  G Assmann; H Schriewer; W Oberwittler
Journal:  Klin Wochenschr       Date:  1980-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.